Nootropic Research Highlights

The nootropics space is moving fast. Here is a digest of recent findings worth knowing about.

Lion's Mane and Neurogenesis

A 2023 study from the University of Queensland identified two new compounds in lion's mane mushroom (Hericium erinaceus) — hericene A and isohericerinol A — that stimulate nerve growth factor (NGF) synthesis at significantly higher potency than previously studied compounds. In vitro and rodent models showed enhanced hippocampal neuron growth and improved memory performance.

Earlier 2019 clinical data showing reversal of mild cognitive impairment in older adults continues to be replicated. The emerging picture is that lion's mane works through dual mechanisms: direct NGF stimulation and modulation of BDNF (brain-derived neurotrophic factor). Dosing in clinical trials has been 500–1000 mg of standardized extract daily. Look for products specifying hericenone and erinacine content — these are the active fractions.

Phosphatidylserine: Updated Dosing Research

Phosphatidylserine (PS) is one of the few nootropics with an FDA-qualified health claim for cognitive decline. New data suggests the optimal dose may be lower than previously assumed. A 2024 study found that 100 mg/day of soy-derived PS produced equivalent memory improvements to 300 mg/day over 12 weeks in adults aged 50–75, suggesting that the standard 300 mg dose may be unnecessarily high for most users.

PS supports membrane fluidity in neurons and plays a critical role in the clearance of cortisol. Its stress-reducing effects appear independently of its memory benefits.

Bacopa Monnieri: The Patience Supplement

New meta-analytic data confirms what previous trials suggested: bacopa requires 8–12 weeks of consistent use before cognitive benefits emerge. Trials measuring outcomes at 4–6 weeks consistently show smaller effects than those run to 12 weeks. The mechanism involves gradual upregulation of serotonin and acetylcholine activity, as well as antioxidant protection of hippocampal neurons.

This makes bacopa a poor candidate for short-term cognitive stacking and an excellent candidate for long-term daily use. Standard dosing: 300–450 mg of standardized extract (45% bacosides) with food.

Citicoline (CDP-Choline)

Citicoline is gaining attention beyond its traditional use in stroke recovery. Recent trials in healthy young adults show that 500–1000 mg/day significantly improves attention, psychomotor speed, and working memory. It works by increasing brain levels of acetylcholine (via choline donation) and uridine (a precursor for membrane phospholipids). Unlike alpha-GPC, citicoline has an additional nootropic action from the cytidine component, which converts to uridine and supports dopamine signaling. It may be the more complete choline source for daily nootropic use.